HPLC/MS analysis of historical pharmaceutical preparations of heroin and cocaine

Analytical Letters

Volumn 43, Issue 16, 2010, Pages 2572-2581

  Nesměrák, Karel ^a   Štícha, Martin ^a   Čvančarova, Monika ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cocaine; Heroin; Long term stability; MS2; MS3; RP HPLC

Indexed keywords

EID: 78649719837     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032711003725649     Document Type: Article

References (24)

1. Barnes, A. R., and S. Nash. 1995. Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion. Pharm. World. Sci. 17: 87-92.
2. Barrett, D. A., A. L. Dyssegaard, and P. N. Shaw. 1992. The effect of temperature and pH on the deacetylation of diamorphine in aqueous solution and in human plasma. J. Pharm. Pharmacol. 44: 606-608.
3. Concheiro, M.,A. de Castro,O.Quintela,M. Lopez-Rivadulla, andA. Cruz. 2006.Determination of drugs of abuse and their metabolites in human plasma by liquid chromatography-mass spectrometry. An application to 156 road fatalities. J. Chrom. B 832: 81-89.
4. Denisov, N. D. 1967. Effect of hydrogen ion concentration on the stability of injection solutions of atropine sulfate, scopolamine hydrobromide and cocaine hydrochloride. Farmatsevtychnyi Zhurnal 22: 74-79. CA 68: 33158 (In Russian.)
5. Ebel, S., and D. Rost. 1980. Stability specific thin-layer chromatographic determination of morphine and its decomposition products. Arch. Pharm. (Weinheim, Ger.) 313: 337-343.
6. Katzung, B. 2006. Basic & Clinical Pharmacology. 10th ed. New York: McGraw Hill.
7. Kleinberg, M. L., M. E. Duafala, C. Nacov, K. P. Flora, J. Hines, K. Davis, A. McDaniel, and D. Scott. 1990. Stability of heroin hydrochloride in infusion devices and containers for intravenous administration. Am. J. Hosp. Pharm. 47: 377-381.
8. Klous, M. G., B. Nuijen, W. van den Brink, J. M. Van Ree, and J. H. Beijnen. 2004. Pharmaceutical development of an intravenous dosage form of diacetylmorphine hydrochloride. PDA J. Pharm. Sci. Technol. 58: 287-295.
9. Long, M. T., A. M. Hailes, G. W. Kirby, and N. C. Bruce. 1995. Transformations of morphine alkaloids by Pseudomonas putida M10. Appl. Environ. Microbiol. 61: 3645-3649.
10. Murray, J. B., and H. Al-Shoura. 1976. Stability of cocaine hydrochloride in aqueous solution. J. Pharm. Pharmacol. 28(Supp.): 24.
11. Omar, O. A., P. J. Hoskin, A. Johnston, G. W. Hanks, and P. Turner. 1989. Diamorphine stability in aqueous solution for subcutaneous infusion. J. Pharm. Pharmacol. 41: 275-277.
12. Payne, H. A. S., and S. M. Tempest. 1988. The chemistry and pharmacy of diamorphine. In Diamorphine: Its Chemistry, Pharmacology, and Clinical use. ed. D. B. Scott. Cambridge, MA: Woodhead-Faulkner, p. 1-14.
13. Poochikian, G. K., and J. C. Cradock. 1980. Stability of Brompton mixtures: Determination of heroin (diacetylmorphine) and cocaine in presence of their hydrolysis products. J. Pharm. Sci. 69: 637-639.
14. Přibyl, R. 1953. Oldřich Tomíček. Chem. Listy 47: 1733-1736. (In Czech.)
15. Raith, K., R. Neubert, C. Pocaknapo, C. Boettcher, M. H. Yenk, and J. Schmidt. 2003. Electrospray tandem mass spectrometry investigation on morphinans. J. Am. Soc. Mass Spectrom. 14: 1262-1269.
16. Roksvaag, P. O., J. B. Fredrikson, and T. Waaler. 1980. High-performance liquid chromatographic assay of morphine and the main degradation product pseudo-morphine. A study of pH, discoloration and degradation in 1 to 43 years old morphine injections. Pharma. Acta Helvetiae 55: 198-202.
17. Rook, E. J., E. J. Hillebrand, H. Rosing, M. J. van Ree, and J. H. Beijnen. 2005. The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry. J. Chrom. B 824: 213-221.
18. Sánchez del Aguila, M. J., M. F. Jones, and A. Vohra. 2003. Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: A study on their long-term stability. Br. J. Anaesth. 90: 179-182.
19. Tsumura, Y., T. Mitome, and S. Kimoto. 2005. False positives and false negatives with a cocaine-specific field test and modification of test protocol to reduce false decision. Forensic Sci. Internat. 155: 154-168.
20. United Nations. 2005. Methods for Impurity Profiling of Heroin and Cocaine. Manual for use by national drug testing laboratories. New York: United Nations.
21. Votavová, J. 1984. Dr. O. Tomíček and his analytical school. Ceska Slov. Farm. 33: 213-214. (In Czech.)
22. Wang, P., and M. G. Bartlett. 1998. Collision-induced dissociation mass spectra of cocaine, and its metabolites and pyrolysis products. J. Mass Spectrom. 33: 961-967.
23. Wheeler, D. M., T. H. Kinstle, and K. L. Rinehart. 1967. Mass spectral studies of alkaloids related to morphine. J. Am. Chem. Soc. 89: 4494-4501.
24. Zhang, Z., B. Yan, K. Liu, T. Bo, Y. Liao, and H. Liu. 2008. Fragmentation pathways of heroin-related alkaloids revealed by ion trap and quadrupole time-of-flight tandem mass spectrometry. Rapid Commun. Mass Spectrom. 22: 2851-2862.